A phase II study of cabozantinib (XL184) in patients with advanced/metastatic urothelial carcinoma.
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Andrea Borghese Apolo, Howard L. Parnes, Ravi Amrit Madan, James L. Gulley, John Joseph Wright, Kattie Khadar, Jane B. Trepel, Jeffrey Schlom, Philip M. Arlen, Maria Merino, Seth M. Steinberg, Peter L. Choyke, Maria Liza Lindenberg, Karen A. Kurdziel, Les Folio, William Douglas Figg, Piyush K. Agarwal, Donald P. Bottaro, William L. Dahut
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2595977189